{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:06:29Z","timestamp":1790089589395,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2875,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.jacc.2004.08.070","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T14:15:43Z","timestamp":1126793743000},"page":"986-993","source":"Crossref","is-referenced-by-count":152,"title":["Aspirin Resistance and Atherothrombotic Disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Peter J.","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice K.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2004.08.070_bib1","first-page":"38","article-title":"Experiences with aspirin (acetylsalicyclic acid) in the non-specific prophylaxis of coronary thrombosis","volume":"75","author":"Craven","year":"1953","journal-title":"Miss Valley Med J"},{"key":"10.1016\/j.jacc.2004.08.070_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2004.08.070_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2004.08.070_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib6","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction","volume":"13","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.08.070_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","article-title":"Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients","volume":"71","author":"Grotemeyer","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2004.08.070_bib8","first-page":"221","article-title":"Individual variation in the effects of ASA on platelet function","volume":"11","author":"Buchanan","year":"1995","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib9","first-page":"801","article-title":"Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy","volume":"118","author":"Pappas","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment","volume":"43","author":"Chen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.08.070_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.08.070_bib16","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.08.070_bib17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinte.163.10.1145","article-title":"Aspirin and clopidogrel in acute coronary syndromes","volume":"163;","author":"Jneid","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib18","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.119.1_suppl.39S","article-title":"Platelet-active drugs","volume":"119","author":"Patrono","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2004.08.070_bib19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.ATV.0000104005.92603.f2","article-title":"Cyclooxygenase-2 expression and inhibition in atherothrombosis","volume":"24","author":"Cipollone","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2004.08.070_bib21","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1073\/pnas.112202999","article-title":"Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets","volume":"99","author":"Rocca","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2004.08.070_bib22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1018644212794","article-title":"Effect of short-term aspirin use on C-reactive protein","volume":"9","author":"Feng","year":"2000","journal-title":"J Thromb Thrombol"},{"key":"10.1016\/j.jacc.2004.08.070_bib25","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0735-1097(01)01289-X","article-title":"Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations","volume":"37","author":"Feldman","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib26","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1161\/01.CIR.0000017863.52347.6C","article-title":"Prevention of inflammation-induced endothelial dysfunction","volume":"5;","author":"Kharbanda","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib27","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/01.CIR.0000070542.18001.87","article-title":"Interleukin-7-mediated inflammation in unstable angina","volume":"107","author":"Damas","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib28","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","article-title":"Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects","volume":"69","author":"Patriginani","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2004.08.070_bib29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198304073081402","article-title":"Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients","volume":"308","author":"Weksler","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib31","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jacc.2003.09.059","article-title":"Aspirin dose and six-month outcome after an acute coronary syndrome","volume":"43","author":"Quinn","year":"2004","journal-title":"J Am Col Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib32","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/S0002-8703(98)70245-5","article-title":"Assessment of platelet function assays","volume":"135","author":"Nicholson","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2004.08.070_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"82;","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.08.070_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(02)02956-4","article-title":"Effect of a single dose of aspirin on platelets in humans with multiple risk factors for coronary artery disease","volume":"462","author":"Malinin","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2004.08.070_bib35","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.amjcard.2003.08.072","article-title":"Incidence of aspirin nonresponsiveness using the Ultegra rapid platelet function assay-ASA","volume":"92","author":"Wang","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.RES.0000074030.98009.FF","article-title":"CD40-CD40L and platelet function","volume":"92","author":"Freedman","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2004.08.070_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0021-9150(78)90162-4","article-title":"Platelet aggregation studies in coronary artery disease. Part 4. Effect of aspirin","volume":"31","author":"Mehta","year":"1978","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2004.08.070_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2125.1997.00639.x","article-title":"A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers","volume":"44","author":"Marshall","year":"1997","journal-title":"Brit J Clin Pharm"},{"key":"10.1016\/j.jacc.2004.08.070_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0049-3848(02)00210-4","article-title":"Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate","volume":"107","author":"Macchi","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2004.08.070_bib40","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2004.08.070_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jacc.2004.08.070_bib42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0049-3848(91)90085-B","article-title":"Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients","volume":"63","author":"Grotemeyer","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2004.08.070_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0049-3848(02)00405-X","article-title":"Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease","volume":"108","author":"Andersen","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2004.08.070_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.CIR.0000081770.51929.5A","article-title":"Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery","volume":"108","author":"Zimmerman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib45","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0038-1657677","article-title":"Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty","volume":"78","author":"Mueller","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.08.070_bib46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.08.070_bib47","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9149(99)00049-1","article-title":"Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT investigators. Platelet IIb\/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy","volume":"83","author":"Alexander","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib48","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/01.CIR.92.9.2432","article-title":"Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin","volume":"92","author":"Hung","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0049-3848(01)00382-6","article-title":"Platelet hemostasis capacity in smokers. In vitro function analyses with 3.2% citrated blood","volume":"104","author":"Brockmann","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2004.08.070_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ahj.2003.07.011","article-title":"Lack of aspirin effect","volume":"147","author":"Cotter","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2004.08.070_bib51","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib52","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.0000087593.07533.9B","article-title":"Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal anti-inflammatory drugs","volume":"108","author":"Kurth","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jacc.2003.08.062","article-title":"Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients","volume":"43","author":"Pulcinelli","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib54","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0049-3848(00)00277-2","article-title":"Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin","volume":"99","author":"Hurlen","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2004.08.070_bib55","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.89.5.1951","article-title":"Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin","volume":"89","author":"Larsson","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.STR.31.3.591","article-title":"Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin","volume":"31","author":"Kawasaki","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2004.08.070_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0037-1615048","article-title":"Eicosanoids and iso-eicosanoids","volume":"79","author":"Maclouf","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.08.070_bib58","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2004.08.070_bib59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.CIR.97.4.350","article-title":"Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality","volume":"97","author":"Valles","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib60","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/hc4701.099787","article-title":"Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury","volume":"104","author":"Undas","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib61","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.101.9.1013","article-title":"Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists","volume":"101","author":"Michelson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib62","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9149(03)00163-2","article-title":"Durability of platelet inhibition by clopidogrel","volume":"91","author":"Gurbel","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.08.070_bib63","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.08.070_bib64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2796.2002.01027.x","article-title":"Individual variations in platelet inhibition after loading doses of clopidogrel","volume":"252","author":"Jaremo","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2004.08.070_bib65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"Muller","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.08.070_bib66","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109705015585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109705015585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T09:53:12Z","timestamp":1553334792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109705015585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0735109705015585"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2004.08.070","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}